Fidaxomicin, now commonly used to treat Clostridioides difficile infection, selectively targets the bacterium while sparing crucial gut commensals that protect against colonization. However, knowledge ...
The spectacular structure of the protective armor of superbug C.difficile has been revealed for the first time showing the close-knit yet flexible outer layer – like chain mail. This assembly prevents ...
Gastrointestinal tumors remain a global health challenge, with high incidence and mortality. Among them, colorectal cancer (CRC) carries the heaviest burden and serves as a key model for how the gut ...
Known as one of the superbugs that resists most antibiotics, Clostridioides difficile, or C. diff, causes inflammation of the colon and can lead to diarrhea and sometimes death. The stubborn bacteria ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The close-knit, flexible outer layer - like chain mail - which protects superbug C.difficile has been unveiled. The spectacular structure of the protective armour of superbug C.difficile has been ...
An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile. | Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results